Hold Rating on Solventum Corporation Amidst Uncertain Growth and Strategy Execution

August 2024 · 2 minute read

Vik Chopra, an analyst from Wells Fargo, maintained the Hold rating on Solventum Corporation (SOLVResearch Report). The associated price target remains the same with $69.00.

Vik Chopra has given his Hold rating due to a combination of factors surrounding the Solventum Corporation’s current business situation and near-term expectations. The anticipation that the first quarter was likely the peak for organic revenue growth and earnings per share sets a precedent for a projected decline in the second quarter. Additionally, while the company has initiatives in place for SKU rationalization, the expected impact of these efforts will not be evident until the second half of the year. Furthermore, the company has not yet engaged in discussions with Trian, a significant investor, regarding their strategies for value creation, which adds a layer of uncertainty.
Chopra’s assessment also takes into account the company’s recent spin-off from MMM and its upcoming first earnings call, where Solventum Corporation is set to provide more color on its strategies and performance. Financial projections for the second quarter are modest, with sales and EPS estimates slightly below consensus, alongside a decrease in operating margins from the previous quarter. These factors, combined with the focus on long-term turnaround and debt repayment, suggest a cautious outlook, justifying the Hold rating until the company demonstrates clearer progress on its articulated strategies and financial results.

In another report released on July 15, Morgan Stanley also maintained a Hold rating on the stock with a $55.00 price target.

TipRanks tracks over 100,000 company insiders, identifying the select few who excel in timing their transactions. By upgrading to TipRanks Premium, you will gain access to this exclusive data and discover crucial insights to guide your investment decisions. Begin your TipRanks Premium journey today.

Solventum Corporation (SOLV) Company Description:

Solventum originates from two words: ‘solving’ and ‘momentum.’Solving’ captures the company’s dedication to finding breakthrough solutions. The organization will listen closely to health care professionals and never stop solving for them -and the many lives they enhance globally. ‘Momentum’ symbolizes swifter, nimbler innovation. As the independent health care company builds on every achievement, large and small, its momentum propels it past barriers, towards breakthroughs. The new name represents how the independent health care company will focus on solving big health care challenges and emphasizes the tremendous impact it can make on the world.

ncG1vNJzZmilkae4psDSZ5muq5mjsrS%2FyKeqopyVp3uku8xopZ6vo2TAtbvCpKpooJ%2BhsW6%2BwK2gp59dpLtuv86lrZ6mpKq6bq%2FOq6eoqpGptrC6jJqkopyjqXq2usKeqa2ZmaN6qL7OsKuhZZGjsW6%2F06uYrZ2XrnqmxMScrK2hn6N6cnySbGxxcGFrhA%3D%3D